Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C10H14N2 |
Molecular Weight | 162.2316 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CCC[C@H]1C2=CN=CC=C2
InChI
InChIKey=SNICXCGAKADSCV-JTQLQIEISA-N
InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1
Molecular Formula | C10H14N2 |
Molecular Weight | 162.2316 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:07:38 UTC 2023
by
admin
on
Fri Dec 15 15:07:38 UTC 2023
|
Record UNII |
6M3C89ZY6R
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Related Record | Type |
---|
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C221
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
||
|
LIVERTOX |
NBK548698
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
||
|
WHO-ATC |
N07BA01
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
||
|
NDF-RT |
N0000175706
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
||
|
WHO-VATC |
QP53AX13
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
||
|
WHO-VATC |
QN07BA01
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
||
|
EPA PESTICIDE CODE |
56702
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
||
|
NDF-RT |
N0000006496
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
||
|
NCI_THESAURUS |
C73579
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
||
|
NDF-RT |
N0000006496
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
D009538
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
PRIMARY | |||
|
7407
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
PRIMARY | |||
|
100000079991
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
PRIMARY | |||
|
2585
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
PRIMARY | |||
|
C691
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
PRIMARY | |||
|
Nicotine replacement therapy
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
PRIMARY | |||
|
17688
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
PRIMARY | |||
|
89594
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
PRIMARY | |||
|
1107
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
PRIMARY | |||
|
NICOTINE
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
PRIMARY | |||
|
CHEMBL3
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
PRIMARY | |||
|
DB00184
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
PRIMARY | |||
|
DTXSID1020930
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
PRIMARY | |||
|
SUB14645MIG
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
PRIMARY | |||
|
Nicotine
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
PRIMARY | |||
|
54-11-5
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
PRIMARY | |||
|
nicotine
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
PRIMARY | |||
|
SUB30160
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
PRIMARY | |||
|
1920
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
PRIMARY | |||
|
m7879
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
PRIMARY | Merck Index | ||
|
5065
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
PRIMARY | |||
|
6M3C89ZY6R
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
PRIMARY | |||
|
200-193-3
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
PRIMARY | |||
|
6M3C89ZY6R
Created by
admin on Fri Dec 15 15:07:38 UTC 2023 , Edited by admin on Fri Dec 15 15:07:38 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
EP
|
||
|
TARGET -> AGONIST |
NICOTINE IS AN ANTIHERBIVORY ALKALOID AND POTENT PARASYMPATHOMIMETIC STIMULANT AND FOUND IN PLANTS, MOSTLY THOSE IN THE NIGHTSHADE FAMILY. NICOTINE ACTS AS A RECEPTOR AGONIST AT MOST NICOTINIC ACETYLCHOLINE RECEPTORS (NACHRS), EXCEPT AT TWO NICOTINIC RECEPTOR SUBUNITS (NACHR.ALPHA.9 AND NACHR.ALPHA.10) WHERE IT ACTS AS A RECEPTOR ANTAGONIST.
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
USP
|
||
|
SALT/SOLVATE -> PARENT | |||
|
DERIVATIVE -> PARENT |
Carcinogenic substance present in cigarette smoke
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
BINDER->LIGAND |
BINDING
|
||
|
METABOLIC ENZYME -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
BINDING
IC50
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
SUB_CONCEPT->SUBSTANCE | |||
|
SALT/SOLVATE -> PARENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
Nicotine (mg/cigarette)
Domestic = 12.6 SD(1.6)
Imported = 11.1 SD(2.2)
|
||
|
SALT/SOLVATE -> PARENT | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
LABELED -> NON-LABELED | |||
|
INHIBITOR -> TARGET |
BINDS TO NICOTINE PREVENTS ACTION
|
||
|
SUB_CONCEPT->SUBSTANCE | |||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE LESS ACTIVE -> PARENT |
75% is converted into cotintine which is further metabolized.
MAJOR
PLASMA; URINE
|
||
|
METABOLITE -> PARENT |
circulating nicotine is metabolized to cotinine by cytochrome P450 and aldehyde oxidase
MAJOR
|
||
|
METABOLITE -> PARENT |
in animals both N-oxide isomers form, in humans only the transisomers form.
MAJOR
URINE
|
||
|
METABOLITE -> PARENT |
The extent of nicotine N-glucuronidation by African Americans is significantly lower than by Whites.
|
||
|
METABOLITE -> PARENT |
PLASMA; URINE
|
||
|
METABOLITE -> PARENT |
The extent of Cotinine N-glucuronidation by African Americans is significantly lower than by Whites.
|
||
|
METABOLITE INACTIVE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||